If these trials confirm the findings, benralizumab could become the first new therapy approved for eosinophilic exacerbations ...

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

You may have COPD if you notice persistent, prolonged changes to your breathing. Symptoms can include: These symptoms usually worsen over time without treatment. You can also develop conditions ...

The growing prevalence of COPD among women can be attributed to a combination of biological, environmental, and societal ...

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...

Ohtuvayre showed significant improvement in lung function by 12 weeks. Follow-up analyses showed that Ohtuvayre had long-term ...

People with COPD experience more falls and related injuries requiring medical care when using common fall-risk increasing ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

Medicare beneficiaries may pay less for 15 additional prescription drugs as early as 2027 as part of the next round of federal regulators' price negotiations with pharmaceutical manufacturers.

The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts ...